Please try another search
Sensidose AB, a pharmaceutical company, develops and sells individualized dosages of tablets for optimal medical treatment of Parkinson's disease in Scandinavian markets. Its products include MyFID, a programmable dosing device for tablets; and Flexilev, a prescription drug in the form of small micro-tablets that are taken with the help of a dose dispenser. The company was founded in 1998 and is based in Sollentuna, Sweden. As of May 25, 2023, Sensidose AB operates as a subsidiary of Navamedic ASA.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review